TransCode Therapeutics Inc
NASDAQ:RNAZ
Earnings Announcements
Transcode Therapeutics Inc - Estimate Cash Of Approximately $5.0 Million As Of December 31, 2022
Published: 02/02/2023 00:02 GMT
TransCode Therapeutics Inc (RNAZ) - Transcode Therapeutics Inc - Estimate Cash of Approximately $5.0 Million As of December 31, 2022.
Further Company Coverage: Rnazo ((reuters.
Briefs@thomsonreuters.
Com;)).
Further Company Coverage: Rnazo ((reuters.
Briefs@thomsonreuters.
Com;)).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.38
Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be $0.00
More details on our Analysts Page.
Adjusted EPS is expected to be -$0.38
Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be $0.00
More details on our Analysts Page.